Literature DB >> 26661636

Results of a Fifteen-Year Follow-up Program in Patients Operated with Unilateral Neck Exploration for Primary Hyperparathyroidism.

Mark Thier1,2, Erik Nordenström3, Martin Almquist3, Anders Bergenfelz3.   

Abstract

BACKGROUND: Since the introduction of unilateral parathyroidectomy for primary hyperparathyroidism (pHPT) it has been debated wherever this approach is associated with greater long-term risk for recurrence compared to bilateral neck exploration.
METHODS: This is a prospective study based on a structured 15-year follow-up program in patients with non-hereditary, sporadic pHPT, undergoing first time surgery with unilateral or focused neck exploration (unilateral procedures), with the use of intraoperative PTH (iOPTH) between 1989 and 2010.
RESULTS: 292 patients were analyzed. The median age of the patients was 66 years [interquartile range (IQR) 57-75], and 234 (80.4%) were female. The median preoperative level of total calcium was 2.74 mmol/L (IQR 2.63-2.85 mmol/L) and the median PTH level was 10 pmol/L (IQR 7.4-14 pmol/L). The median follow-up time was 5 years (IQR 1-10 years). Some 275 patients were followed for 1 year (94.2%/275 person-years/5 patients deceased), 164 for 5 years (56.2%/820 person-years/31 patients deceased), 70 for 10 years (24.0%/700 patient-years/57 patients deceased) and 51 (17.5%/765 patient-years/69 patients deceased) for 15 years after surgery. Three patients (1.1%) had signs of persistent disease. One patient recurred in pHPT at 5 years postoperatively during 15 years of follow-up. Histopathology indicated solitary parathyroid adenoma at primary surgery.
CONCLUSION: Patients with pHPT operated with unilateral procedures and iOPTH, had a low risk for long-term recurrence during a 15 years follow-up program.

Entities:  

Mesh:

Year:  2016        PMID: 26661636     DOI: 10.1007/s00268-015-3360-6

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  44 in total

1.  The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism.

Authors:  Robert Udelsman; Zhenqiu Lin; Patricia Donovan
Journal:  Ann Surg       Date:  2011-03       Impact factor: 12.969

2.  Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial.

Authors:  Anders Bergenfelz; Pia Lindblom; Sten Tibblin; Johan Westerdahl
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

3.  Are additional localization studies and referral indicated for patients with primary hyperparathyroidism who have negative sestamibi scan results?

Authors:  Dina M Elaraj; Rebecca S Sippel; Sheila Lindsay; Ileana Sansano; Quan-Yang Duh; Orlo H Clark; Electron Kebebew
Journal:  Arch Surg       Date:  2010-06

4.  Values of ultrasonography, sestamibi scintigraphy, and intraoperative measurement of 1-84 PTH for unilateral neck exploration of primary hyperparathyroidism.

Authors:  Y Chapuis; Y Fulla; P Bonnichon; E Tarla; B Abboud; J Pitre; B Richard
Journal:  World J Surg       Date:  1996-09       Impact factor: 3.352

Review 5.  Significance of elevated parathyroid hormone after parathyroidectomy for primary hyperparathyroidism.

Authors:  Sarah C Oltmann; Naim M Maalouf; Shelby Holt
Journal:  Endocr Pract       Date:  2011 Mar-Apr       Impact factor: 3.443

6.  Patients with elevated serum parathyroid hormone levels after parathyroidectomy: showing signs of decreased peripheral parathyroid hormone sensitivity.

Authors:  Erik Nordenström; Johan Westerdahl; Anders Isaksson; Pia Lindblom; Anders Bergenfelz
Journal:  World J Surg       Date:  2003-02       Impact factor: 3.352

7.  Preoperative sestamibi localization combined with intraoperative parathyroid hormone assay predicts successful focused unilateral neck exploration during surgery for primary hyperparathyroidism.

Authors:  Pringl Miller; Amanda Kindred; Daniel Kosoy; David Davidson; Hewitt Lang; Kenneth Waxman; James Dunn; Ronald G Latimer
Journal:  Am Surg       Date:  2003-01       Impact factor: 0.688

8.  Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial.

Authors:  Jens Bollerslev; Svante Jansson; Charlotte L Mollerup; Jörgen Nordenström; Eva Lundgren; Ove Tørring; Jan-Erik Varhaug; Marek Baranowski; Sylvi Aanderud; Celina Franco; Bo Freyschuss; Gunhild A Isaksen; Thor Ueland; Thord Rosen
Journal:  J Clin Endocrinol Metab       Date:  2007-02-06       Impact factor: 5.958

9.  Outcomes after subtotal parathyroidectomy for primary hyperparathyroidism due to hyperplasia: significance of whole vs. partial gland remnant.

Authors:  Mohammad H Rajaei; Sarah C Oltmann; David F Schneider; Rebecca S Sippel; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2014-09-23       Impact factor: 5.344

10.  Surgery for patients with primary hyperparathyroidism and negative sestamibi scintigraphy--a feasibility study.

Authors:  Mark Thier; Erik Nordenström; Anders Bergenfelz; Johan Westerdahl
Journal:  Langenbecks Arch Surg       Date:  2009-06-23       Impact factor: 3.445

View more
  2 in total

Review 1.  Updates in primary hyperparathyroidism.

Authors:  Guido Gasparri
Journal:  Updates Surg       Date:  2017-06-23

Review 2.  Systematic review of cure and recurrence rates following minimally invasive parathyroidectomy.

Authors:  H Ishii; R Mihai; J C Watkinson; D S Kim
Journal:  BJS Open       Date:  2018-05-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.